Results 201 to 210 of about 96,395 (289)

Exploring the Antidiabetic and Lipid‐Lowering Properties of Nepali Wild Turmeric (Curcuma aromatica): A Potential Natural Remedy

Food Safety and Health, EarlyView.
Curcuma aromatica rhizome ethanolic extracts (400 mg/kg) showed hypoglycemic and hypolipidemic activities in alloxan‐induced diabetic rats, comparable to standard drugs in reducing blood glucose levels. The extracts reduced serum cholesterol and triglycerides, increased HDL levels, and prevented weight loss.
Salma Khadka, Tshoisang Vaal, Sanjit Gurung, Keshav Dhakal, Ramesh Raj Padhaya, Sailendra Chaudhary, Bipindra Pandey   +6 more
wiley   +1 more source

Statin use and acute kidney injury among hospitalized chronic kidney disease patients: a retrospective cohort study. [PDF]

Front Med (Lausanne)
Tang LE, Xu DM, Xu LY, Zhao YL, Zhu YD, Lv JC, Yang L, Zheng XZ.   +7 more
europepmc   +1 more source

Safety and Efficacy Findings From a Phase Ib/II Study of ASP‐1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background ASP‐1929 photoimmunotherapy—cetuximab conjugated to IRDye 700DX and red light (690 nm) for localized drug activation—results in rapid, selective cell killing. Methods This phase Ib/II open‐label study evaluated ASP‐1929 photoimmunotherapy plus pembrolizumab in patients with recurrent/metastatic HNSCC (≥ 1 accessible lesion, PD‐L1 ...
David M. Cognetti, Joseph M. Curry, Jennifer Johnson, Michael Kwon, Shirley Y. Su, Francisco Civantos, Coral Olazagasti, Joseph Valentino, Susanne M. Arnold, R. Bryan Bell, Michael K. Gibson, Kyle Mannion, Kathryn M. Van Abel, Katharine A. Price, Haiying Dong, Amy H. Thorne, Toshiaki Suzuki, Ann M. Gillenwater   +17 more
wiley   +1 more source

New Frontiers for Old Medications: Repurposing Approved Drugs Against Gram-Negative Bacterial Infections. [PDF]

Microorganisms
Aloni-Grinstein R, Mamroud E, Gal Y.
europepmc   +1 more source

Inflammation-Driven Genomic Instability: A Pathway to Cancer Development and Therapy Resistance. [PDF]

Pharmaceuticals (Basel)
Rembiałkowska N, Kocik Z, Kłosińska A, Kübler M, Pałkiewicz A, Rozmus W, Sędzik M, Wojciechowska H, Gajewska-Naryniecka A.   +8 more
europepmc   +1 more source

A Retrospective Data Analysis of Patients Treated with Difluprednate and Bromfenac for Cystoid Macular Edema After Uveitis or Cataract Surgery. [PDF]

Clin Ophthalmol
Shah N, Tran E, Caballero-Ortiz S, Kyveris A, Chan T.   +4 more
europepmc   +1 more source

Can we improve the existing management of pain after cesarean delivery at Eastern Regional Referral Hospital? A retrospective study. [PDF]

BMC Anesthesiol
Wangchuk T, Tshering U.
europepmc   +1 more source

A case report: Diagnosis and treatment of idiopathic hypertrophic pachymeningitis

Ibrain, Volume 11, Issue 1, Page 112-116, Spring 2025.
We reported a case of idiopathic hypertrophic dura meningitis diagnosed in our hospital. The patient repeatedly suffered from headaches, followed by blurred vision in the right eye. During this period, multiple sclerosis was considered for diagnosis, and it improved after hormone treatment.
Zhong Luo, Piao Cao, Jing‐Qing Xu, Rong Yan, Jian Wang, Tao Liang, Ya Chen, Zu‐Cai Xu   +7 more
wiley   +1 more source

Effectiveness of a formulary system on prophylactic oral proton pump inhibitors for drug-induced peptic ulcer in a Japanese tertiary hospital: an interrupted time series analysis. [PDF]

J Pharm Health Care Sci
Ishida R, Yamada N, Sato K, Maekawa A, Kamei T, Akagi S, Tokuda H, Tokumasu H, Mizuno M, Takayanagi K.   +9 more
europepmc   +1 more source

Research progress of neurovascular units involved in ischemic stroke

Ibrain, EarlyView.
The brain receives less blood when an ischemic stroke develops, which damages neurons and leads to an increased release of Pro‐inflammatory mediators that activate neurovascular unit (NVU). When the tight junctions are broken and the basement membrane is disrupted by matrix metalloproteinases produced by active endothelial and pericellular cells ...
Yu Yang, Hao Tong, Zhuo‐Fan Ye, Zu‐Cai Xu, Tao Tao   +4 more
wiley   +1 more source